Systematic Intervention for Children with Autism Spectrum Disorder and Integration in Regular School Classes: A Naturalistic Study

Autor: Sotiris I. Kotsopoulos MD, PhD, FRCPC, Katerina Karaivazoglou MD, PhD (child psychiatrist), Irene S. Florou Msc (psychologist), Maria I. Gyftogianni MA (speech therapist), Ermioni J. Papadaki MA (social worker), Angelique Kotsopoulou PhD (speech pathologist)

Publikováno v: Global Pediatric Health, Vol 8 (2021)

Objective of the present study was the assessment of the effect of a systematic community intervention offered at an early age to 32 children with autism spectrum disorder (ASD), 2 to 5 year after completion of treatment while attending public school

Externí odkaz: https://doaj.org/article/aa16483bd078482e8b4dc8b7cc5dc05b

Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab.

Autor: Monastirioti A; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece., Papadaki C; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece., Kalapanida D; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Heraklion, Crete, Greece., Rounis K; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece.; Thoracic Oncology Center, Theme Cancer, Karolinska University Hospital, 17164 Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden., Michaelidou K; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece., Papadaki MA; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece., Mavroudis D; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Heraklion, Crete, Greece., Agelaki S; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Heraklion, Crete, Greece.

Publikováno v: Cancers [Cancers (Basel)] 2022 Sep 28; Vol. 14 (19). Date of Electronic Publication: 2022 Sep 28.

Single-Cell RNA Sequencing Uncovers Heterogeneous Circulating Tumor Cell Subsets in Breast Cancer.

Autor: Papadaki MA; Laboratory of Translational Oncology, School of Medicine, University of Crete, 70013 Heraklion, Greece., Agelaki S; Laboratory of Translational Oncology, School of Medicine, University of Crete, 70013 Heraklion, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, 71110 Heraklion, Greece.

Publikováno v: Cancers [Cancers (Basel)] 2022 Mar 04; Vol. 14 (5). Date of Electronic Publication: 2022 Mar 04.

MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer.

Autor: Papadaki C; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Vassilika Vouton, 71003 Crete, Greece., Thomopoulou K; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Crete, Greece., Monastirioti A; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Vassilika Vouton, 71003 Crete, Greece., Koronakis G; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Crete, Greece., Papadaki MA; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Vassilika Vouton, 71003 Crete, Greece., Rounis K; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Crete, Greece., Vamvakas L; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Crete, Greece., Nikolaou C; Department of Biology, University of Crete, Heraklion, Vassilika Vouton, 70013 Crete, Greece.; Institute of Molecular Biology and Biotechnology (IMBB), Foundation of Research and Technology (FORTH), Heraklion, Vassilika Vouton, 70013 Crete, Greece.; Biomedical Science Research Center 'Alexander Fleming', Institute of Bioinnovation, 16672 Athens, Greece., Mavroudis D; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Vassilika Vouton, 71003 Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Crete, Greece., Agelaki S; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Vassilika Vouton, 71003 Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Crete, Greece.

Publikováno v: Biomedicines [Biomedicines] 2021 Apr 13; Vol. 9 (4). Date of Electronic Publication: 2021 Apr 13.

Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.

Autor: Papadaki MA; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece., Aggouraki D; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece., Vetsika EK; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece., Xenidis N; Department of Medical Oncology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.; Hellenic Oncology Research Group (HORG), Athens, Greece., Kallergi G; Hellenic Oncology Research Group (HORG), Athens, Greece.; Department of Biology, University of Patras, Patras, Greece., Kotsakis A; Hellenic Oncology Research Group (HORG), Athens, Greece.; Department of Medical Oncology, University Hospital of Larissa & Laboratory of Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece., Georgoulias V; Hellenic Oncology Research Group (HORG), Athens, Greece; georgulv@otenet.gr.; School of Medicine, University of Crete, Heraklion, Greece.

Publikováno v: Anticancer research [Anticancer Res] 2021 Feb; Vol. 41 (2), pp. 661-670.